Investment analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright raised their target price on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th.
Read Our Latest Stock Analysis on SenesTech
SenesTech Stock Performance
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- Learn Technical Analysis Skills to Master the Stock Market
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- How to Invest in the FAANG Stocks
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Financial Services Stocks Investing
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.